These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [From disease proteomics to biomarker development-establishment of antibody proteomics technology and exploration of cancer-related biomarkers]. Nagano K; Imai S; Nakagawa S; Tsunoda S; Tsutsumi Y Yakugaku Zasshi; 2010 Apr; 130(4):487-92. PubMed ID: 20371990 [TBL] [Abstract][Full Text] [Related]
8. [Search for breast cancer-related biomarker proteins for drug discovery]. Nagano K Yakugaku Zasshi; 2010 Dec; 130(12):1701-6. PubMed ID: 21139398 [TBL] [Abstract][Full Text] [Related]
9. Oncoproteomics: current trends and future perspectives. Cho WC; Cheng CH Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924 [TBL] [Abstract][Full Text] [Related]
10. Design of high-density antibody microarrays for disease proteomics: key technological issues. Borrebaeck CA; Wingren C J Proteomics; 2009 Aug; 72(6):928-35. PubMed ID: 19457338 [TBL] [Abstract][Full Text] [Related]
11. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays. Gupta S; Manubhai KP; Mukherjee S; Srivastava S Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893 [TBL] [Abstract][Full Text] [Related]
12. Protein microarrays for cancer diagnostics and therapy. Lin JC Med Princ Pract; 2010; 19(4):247-54. PubMed ID: 20516699 [TBL] [Abstract][Full Text] [Related]
13. Recombinant antibody microarray for profiling the serum proteome of SLE. Borrebaeck CA; Sturfelt G; Wingren C Methods Mol Biol; 2014; 1134():67-78. PubMed ID: 24497355 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins. Desrosiers RR; Beaulieu E; Buchanan M; Béliveau R Cell Biochem Biophys; 2007; 49(3):182-95. PubMed ID: 17952643 [TBL] [Abstract][Full Text] [Related]
16. Innovations, challenges and future prospects of oncoproteomics. Jain KK Mol Oncol; 2008 Aug; 2(2):153-60. PubMed ID: 19383334 [TBL] [Abstract][Full Text] [Related]
17. Multiplexed protein profiling by sequential affinity capture. Ayoglu B; Birgersson E; Mezger A; Nilsson M; Uhlén M; Nilsson P; Schwenk JM Proteomics; 2016 Apr; 16(8):1251-6. PubMed ID: 26935855 [TBL] [Abstract][Full Text] [Related]
19. Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins. Imai S; Nagano K; Yoshida Y; Okamura T; Yamashita T; Abe Y; Yoshikawa T; Yoshioka Y; Kamada H; Mukai Y; Nakagawa S; Tsutsumi Y; Tsunoda S Biomaterials; 2011 Jan; 32(1):162-9. PubMed ID: 20933274 [TBL] [Abstract][Full Text] [Related]
20. Using protein microarrays to study cancer. Sreekumar A; Chinnaiyan AM Biotechniques; 2002 Dec; Suppl():46-53. PubMed ID: 12514929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]